Philip Irwin Motakatla - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Current Drug Targets|October 23, 2025

Rationally Engineered Small Molecules: Pharmacophore Modeling and Molecular Docking Studies Targeting Toxic Polyglutamine (PolyQ) Repeats in Huntington's DiseaseJangampalli Adi Pradeepkiran, Amardev Rajesh Vatapatri, Philip Irwin Motakatla, et al.

Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 13, 2025

Small molecule DDQ involvement of ERK-mediated signaling pathway with enhanced mitophagy in HT22 cells transfected with mTauJangampalli Adi Pradeepkiran, Sudhir Kshirsagar, Rainier Vladlen Alvir, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Current Drug Targets|October 23, 2025

Rationally Engineered Small Molecules: Pharmacophore Modeling and Molecular Docking Studies Targeting Toxic Polyglutamine (PolyQ) Repeats in Huntington's DiseaseJangampalli Adi Pradeepkiran, Amardev Rajesh Vatapatri, Philip Irwin Motakatla, et al.

Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 13, 2025

Small molecule DDQ involvement of ERK-mediated signaling pathway with enhanced mitophagy in HT22 cells transfected with mTauJangampalli Adi Pradeepkiran, Sudhir Kshirsagar, Rainier Vladlen Alvir, et al.

Pageof 1